HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of 4-hexadecyl-4,7-diaza-1,10-decanedithiol (HDD) kit for the preparation of the liver cancer therapeutic agent Re-188-HDD/lipiodol.

AbstractINTRODUCTION:
A lipiodol solution of (188)Re-4-hexadecyl-2,2,9,9-tetramethyl-4,7-diaza-1,10-decanedithiol (HTDD) has been successfully developed for liver cancer therapy; however, its preparation requires a multi-step synthesis and it is characterized by a low labeling yield.
METHODS:
We synthesized a new compound, 4-hexadecyl-4,7-diaza-1,10-decanedithioacetate (AHDD), without gem dimethyl groups to address these issues. AHDD was formulated into a kit and was labeled with (188)Re. Biodistribution study was performed using normal BALB/c mice.
RESULTS:
The kit was labeled with (188)Re with a high efficiency (98.8±0.2%). After extraction with lipiodol, the overall yield of (188)Re-HDD/lipiodol was as high as 90.2±2.6%. A comparative biodistribution study of (188)Re-HTDD and (188)Re-HDD was performed in normal mice after intravenous injection. The lungs were identified as the main uptake site due to capillary-blockage. (188)Re-HDD/lipiodol showed a significantly higher lung uptake than that of (188)Re-HTDD/lipiodol (p<0.05).
CONCLUSION:
The newly synthesized (188)Re-HDD/lipiodol showed improved radiolabeling yield and biodistribution results compared to (188)Re-HTDD/lipiodol, and may therefore be more suitable for liver cancer therapy.
AuthorsVinay Kumar Banka, Sung-Hyun Moon, Jae Min Jeong, Sudhakara Reddy Seelam, Yun-Sang Lee, Young Joo Kim, Dong Soo Lee, June-Key Chung
JournalNuclear medicine and biology (Nucl Med Biol) Vol. 42 Issue 3 Pg. 317-22 (Mar 2015) ISSN: 1872-9614 [Electronic] United States
PMID25537725 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • 188Re 4-hexadecy-2,2,9,9-tetramethyl-4,7-diaza-1,10-decanedithiol
  • Coordination Complexes
  • Organometallic Compounds
  • Radioisotopes
  • Cysteamine
  • Rhenium
  • Ethiodized Oil
Topics
  • Animals
  • Chemistry Techniques, Synthetic
  • Chemistry, Pharmaceutical
  • Coordination Complexes (chemical synthesis, chemistry, pharmacokinetics, therapeutic use)
  • Cysteamine (analogs & derivatives, chemical synthesis, chemistry, pharmacokinetics, therapeutic use)
  • Drug Compounding
  • Drug Design
  • Embolization, Therapeutic
  • Ethiodized Oil (chemistry)
  • Liver Neoplasms (therapy)
  • Mice
  • Mice, Inbred BALB C
  • Organometallic Compounds
  • Radiochemistry
  • Radioisotopes (therapeutic use)
  • Rhenium (therapeutic use)
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: